DiaMedica Therapeutics Inc. - Common Stock — 四半期キャッシュフロー (NASDAQ:DMAC) | MetaTrader

チャート全体を表示 Full chart

Financials

概要明細書統計

総資産 46.34 M38.83 M31.47 M57.05 M61.37 M53.08 M 負債合計 5.63 M4.88 M4.3 M5.42 M5.26 M5.84 M 純資産合計 40.72 M33.95 M27.17 M51.62 M56.11 M47.23 M 負債および純資産合計 46.34 M38.83 M31.47 M57.05 M61.37 M53.08 M 有利子負債合計 —————— 純負債 ——————

ニュース

Top Wall Street Forecasters Revamp DiaMedica Therapeutics Expectations Ahead Of Q4 Earnings - DiaMedica Therapeutics (NASDAQ:DMAC)

DiaMedicaが子癇前症研究でカナダ保健省の承認を取得

DiaMedica receives Health Canada clearance for preeclampsia study

キャンター・フィッツジェラルド、DiaMedicaの株式に対する「買い」評価を維持

Cantor Fitzgerald reiterates Overweight rating on DiaMedica stock

DiaMedicaが妊娠高血圧症候群治療薬の追加研究を実施へ

DiaMedica to conduct additional study for preeclampsia treatment

Cisco, Flutter, Manulife and more set to report earnings Wednesday

TD CowenがDiaMedica Therapeuticsに「買い」の評価を開始

DiaMedica Therapeutics stock initiated with Buy rating at TD Cowen

Tracking Leon Cooperman’s ~$3B Omega Advisors Portfolio – Q2 2025 Update

DiaMedica Therapeutics, Inc. (DMAC) is a Great Momentum Stock: Should You Buy?